Inherent Biosciences

BiotechnologySeries ASalt Lake City, USinherentbio.com

Latest round

Series A

Last raised

Sep 2022

Total raised

$2.5M

Investors

8

About Inherent Biosciences

Based in Utah, US, and founded in 2019 by Andy Olson (CEO), and Kristin Brogaard (CSO), Inherent Biosciences is a diagnostics and therapeutics company that offers epigenetic medicine for complex diseases such as gene dysregulation. The firm uses its epigenetic platform to detect dysregulation across multiple genes and related pathways to diagnose in early stages and treat diseases like infertility, autoimmune disease, autism, and other complex diseases. The company offers products that help patients suffering from infertility, detect prostate cancer, predict embryo quality, and the need for IVF.

Who invested in Inherent Biosciences

8 investors across 2 rounds

See all investors in Inherent Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 6, 2022

    Amount

    Undisclosed

    Investors

    Locked

  2. Seed

    Feb 17, 2021

    Amount

    $2.5M

    Investors

    Locked

Questions about Inherent Biosciences

Who invested in Inherent Biosciences?

Inherent Biosciences has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Inherent Biosciences raised?

Inherent Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Inherent Biosciences last raise money?

Inherent Biosciences's most recent round on record is a Series A, in Sep 2022.

What does Inherent Biosciences do?

Based in Utah, US, and founded in 2019 by Andy Olson (CEO), and Kristin Brogaard (CSO), Inherent Biosciences is a diagnostics and therapeutics company that offers epigenetic medicine for complex diseases such as gene dysregulation.

Where is Inherent Biosciences headquartered?

Inherent Biosciences is headquartered in Salt Lake City, US.

Which VCs invest in companies like Inherent Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inherent Biosciences's stage. Their profiles are linked below.

Raising like Inherent Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.